Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

mcneil products ltd - paracetamol - oral suspension - 50mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

mcneil products ltd - paracetamol - oral suspension - 24mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

mcneil products ltd - paracetamol - oral suspension - 24mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

thornton & ross ltd - methadone hydrochloride - oral solution - 1mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

mcneil products ltd - paracetamol - oral suspension - 24mg/1ml

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

perrigo pharma international designated activity company - methadone hydrochloride - oral solution - 1 milligram(s)/millilitre - drugs used in opioid dependence; methadone

Marekani - Kiingereza - NLM (National Library of Medicine)

lannett company, inc. - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - methadone hydrochloride contains methadone, an opioid agonist indicated for the: - detoxification treatment of opioid addiction (heroin or other morphine-like drugs). - maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services. limitations of use methadone products used for the treatment of opioid addiction in detoxification or maintenance programs are subject to the conditions for distribution and use required under 21 cfr, title 42, sec 8 [see dosage and administration (2.1)] . methadone hydrochloride is contraindicated in patients with: - significant respiratory depression [see warnings and precautions (5.1)] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings and precautions (5.8)] - known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings and precautions (5.13)] - hypersensitivity (e.g., anaphylaxis) to methadone or any othe

Marekani - Kiingereza - NLM (National Library of Medicine)

bryant ranch prepack - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - - for detoxification treatment of opioid addiction (heroin or other morphine-like drugs). - for maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services. limitations of use methadone products used for the treatment of opioid addiction in detoxification or maintenance programs are subject to the conditions for distribution and use required under 21 cfr, title 42, sec 8 (see  dosage and administration ). methadone hydrochloride is contraindicated in patients with: - significant respiratory depression significant respiratory depression - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment - known or suspected gastrointestinal obstruction, including paralytic ileus known or suspected gastrointestinal obstruction, including paralytic ileus - hypersensitivity (e.g., anaph

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

taw pharma (ireland) limited - methadone hydrochloride - oral solution - 1 milligram(s)/millilitre - drugs used in opioid dependence; methadone

Marekani - Kiingereza - NLM (National Library of Medicine)

atlantic biologicals corp. - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - - for detoxification treatment of opioid addiction (heroin or other morphine-like drugs). - for maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services. limitations of use methadone products used for the treatment of opioid addiction in detoxification or maintenance programs are subject to the conditions for distribution and use required under 21 cfr, title 42, sec 8 (see  dosage and administration ). methadone hydrochloride is contraindicated in patients with: - significant respiratory depression significant respiratory depression - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment - known or suspected gastrointestinal obstruction, including paralytic ileus known or suspected gastrointestinal obstruction, including paralytic ileus - hypersensitivity (e.g., anaph